MC
VRTX icon

Miles Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Miles Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$394K Buy
1,657
+334
+25% +$76.6K 0.42% 65
2019
Q4 		$290K Sell
1,323
-68
-5% -$13.8K 0.23% 110
2019
Q3 		$236K Sell
1,391
-2
-0.1% -$354 0.19% 137
2019
Q2 		$255K Buy
1,393
+169
+14% +$29.5K 0.21% 127
2019
Q1 		$225K Sell
1,224
-125
-9% -$23.1K 0.2% 144
2018
Q4 		$224K Buy
1,349
+7
+0.5% +$1.21K 0.22% 133
2018
Q3 		$259K Buy
+1,342
New +$239K 0.21% 132

Other funds holding VRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Miles Capital's VRTX Position: Q1 2020 in Review

Miles Capital increased its Vertex Pharmaceuticals (VRTX) stake by 25% in Q1 2020, buying an estimated $76.6K and bringing the position to 1,657 shares worth $394K. The position accounts for 0.42% of the portfolio, ranked #65.

Miles Capital first reported a position in VRTX in Q3 2018 and has held it in 7 quarters since. 854 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

  • Miles Capital held 1,657 shares of Vertex Pharmaceuticals worth $394K as of Q1 2020.
  • Miles Capital bought 334 Vertex Pharmaceuticals shares in Q1 2020, an estimated $76.6K.
  • Vertex Pharmaceuticals made up 0.42% of Miles Capital's portfolio in Q1 2020, its #65 holding.
  • Miles Capital first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 7 quarters since.
  • 854 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.